Depression in Patients with Chronic Obstructive Pulmonary Disease

References

• . Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ. 2002;51(6):1–16
   Google Scholar
• . World Health Organization. Chronic obstructive pulmonary disease (COPD): Fact sheet no. 315. Geneva: World Health Organization. http://www.who.int/mediacentre/factsheets/fs315/en/index.html. Last updated February 2011. Accessed July 6, 2011
   Google Scholar
• . Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org. Updated December 2011. Accessed March 16, 2012
   Google Scholar
• . Di Marco F, Verga M, Reggente M, . Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767–1774
   PubMed Web of Science ®Google Scholar
• . Putman–Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung. 2009;38(1):34–47
   PubMed Web of Science ®Google Scholar
• . Schane RE, Walter LC, Dinno A, Covinsky KE, Woodruff PG. Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med. 2008;23(11): 1757–1762
   PubMed Web of Science ®Google Scholar
• . Ahmed K, Kelshiker A, Jenner C. The screening and treatment of undiagnosed depression in patients with chronic obstructive pulmonary disease (COPD) in a general practice. Prim Care Respir J. 2007;16(4):249–251
   PubMedGoogle Scholar
• . Zhang MW, Ho RC, Cheung MW, Fu E, Mak A. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33(3):217–223
   PubMed Web of Science ®Google Scholar
• . Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60–67
   PubMed Web of Science ®Google Scholar
• . Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011;8(4):293–299
   PubMedGoogle Scholar
• . Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2006;12(2):113–117
   PubMed Web of Science ®Google Scholar
• . Kunik ME, Roundy K, Veazey C, . Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–1211
   PubMed Web of Science ®Google Scholar
• . Xu W, Collet JP, Shapiro S, . Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9):913–920
   PubMed Web of Science ®Google Scholar
• . de Voogd JN, Wempe JB, Koëter GH, . Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009;135(3):619–625
   PubMed Web of Science ®Google Scholar
• . DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–2107
   PubMed Web of Science ®Google Scholar
• . Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2001;21(2):80–86
   PubMedGoogle Scholar
• . Laurin C, Lavoie KL, Bacon SL, . Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest. 2007;132(1):148–155
   PubMed Web of Science ®Google Scholar
• . Coultas DB, Edwards DW, Barnett B, Wludyka P. Predictors of depressive symptoms in patients with COPD and health impact. COPD. 2007;4(1):23–28
   PubMedGoogle Scholar
• . Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract. 2007;24(3):217–223
   PubMed Web of Science ®Google Scholar
• . Hanania NA, Mullerova H, Locantore NW, . Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183(5):604–611
   PubMed Web of Science ®Google Scholar
• . Quint JK, Baghai–Ravary R, Donaldson GC, Wedzicha JA. Relationship between depression and exacerbations in COPD. Eur Respir J. 2008;32(1):53–60
   PubMed Web of Science ®Google Scholar
• . Forest Pharmaceuticals Inc. Daliresp prescribing information. US Food and Drug Administration. http://www.accessdata.fda.gov/drug-satfda_docs/label/2011/022522s000lbl.pdf. Updated February 24, 2011. Accessed March 16, 2012
   Google Scholar
• . Pfizer Inc. Chantix prescribing information. US Food and Drug Administration. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021928s028lbl.pdf. Updated January 20, 2012. Accessed March 16, 2012
   Google Scholar
• . Norwood R, Balkissoon R. Current perspectives on management of co-morbid depression in COPD. COPD. 2005;2(1):185–193
   PubMedGoogle Scholar
• . Maurer J, Rebbapragada V, Borson S, ; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134( 4 suppl):43S–56S
   PubMed Web of Science ®Google Scholar
• . van Eijk JT, Diederiks JP, Kempen GI, Honig A, van der Meer K, Brenninkmeijer WJ. Development and feasibility of a nurse administered strategy on depression in community-dwelling patients with a chronic physical disease. Patient Educ Couns. 2004;54(1):87–94
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, third edition. American Psychiatric Association. http://www.psychiatryonline.com/pracGuide/PracticePDFs/PG_Depression3rdEd.pdf. Updated October 2010. Accessed July 6, 2011
   Google Scholar
• . Julian LJ, Gregorich SE, Earnest G, . Screening for depression in chronic obstructive pulmonary disease. COPD. 2009;6(6):452–458
   PubMedGoogle Scholar
• . Spitzer RL, Williams JB, Kroenke K, . Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272(22):1749–1756
   PubMed Web of Science ®Google Scholar
• . Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613
   PubMed Web of Science ®Google Scholar
• . Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–1744
   PubMed Web of Science ®Google Scholar
• . Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics. 1992;33(2):190–201
   PubMed Web of Science ®Google Scholar
• . Evans M, Hammond M, Wilson K, Lye M, Copeland J. Placebo-controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry. 1997;12(8):817–824
   PubMed Web of Science ®Google Scholar
• . Lacasse Y, Beaudoin L, Rousseau L, Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis. 2004;61(3): 140–147
   PubMedGoogle Scholar
• . Eiser N, Harte R, Spiros K, Phillips C, Isaac MT. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD. 2005;2(2):233–241
   PubMedGoogle Scholar
• . National Collaborating Centre for Mental Health. Depression in adults with a chronic physical health problem: treatment and management. National Institute for Health and Clinical Excellence. http://www.nice.org.uk/nicemedia/pdf/CG91FullGuideline.pdf. Accessed March 16, 2012
   Google Scholar
• . Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev. 2010;3:CD007503
   Google Scholar
• . Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev. 2006;1:CD003491
   PubMedGoogle Scholar
• . Bratås O, Espnes GA, Rannestad T, Walstad R. Pulmonary rehabilitation reduces depression and enhances health-related quality of life in COPD patients-especially in patients with mild or moderate disease. Chron Respir Dis. 2010;7(4):229–237
   PubMedGoogle Scholar
• . Alexopoulos GS, Sirey JA, Raue PJ, Kanellopoulos D, Clark TE, Novitch RS. Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. Am J Geriatr Psychiatry. 2006;14(5): 466–475
   PubMed Web of Science ®Google Scholar
• . Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med. 2010;104(7):986–994
   PubMed Web of Science ®Google Scholar
• . Livermore N, Sharpe L, McKenzie D. Panic attacks and panic disorder in chronic obstructive pulmonary disease: a cognitive behavioral perspective. Respir Med. 2010;104(9):1246–1253
   PubMed Web of Science ®Google Scholar
• . Kraus CA, Kunik ME, Stanley MA. Use of cognitive behavioral therapy in late-life psychiatric disorders. Geriatrics. 2007;62(6):21–26
   PubMed Web of Science ®Google Scholar
• . Kendrick T, Dowrick C, McBride A, . Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. BMJ. 2009; 338:B750
   PubMedGoogle Scholar